TCL Archive Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief. December 19, 2008
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
